Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v6-EN
Language English English
Date Updated 2021-10-15 2021-10-14
Drug Identification Number 02440229 02440229
Brand name NAT-LEVETIRACETAM NAT-LEVETIRACETAM
Common or Proper name LEVETIRACETAM Tablets LEVETIRACETAM Tablets
Company Name NATCO PHARMA (CANADA) INC NATCO PHARMA (CANADA) INC
Ingredients LEVETIRACETAM LEVETIRACETAM
Strength(s) 750MG 750MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 120 120
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-08-01 2019-08-01
Actual start date
Estimated end date
Actual end date 2021-10-14 2021-10-14
Shortage status Resolved Actual shortage
Company comments
Health Canada comments